Capacity: Education and Training
TIP 63: Medications for Opioid Use Disorder
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.
Essentials of Opioid Use Disorder: A Resource for Hepatologists and Infectious Disease Specialists Managing HCV and/or HIV Infection
Download this PDF guide outlining key information on identifying and treating opioid use disorder among patients with HIV and or HCV infection.
American Society of Addiction Medicine: Appropriate Use of Drug Testing in Clinical Addiction Medicine
This resource provides guidance about the effective use of drug testing in the identification, diagnosis, treatment, and promotion of recovery for patients with, or at risk for, addiction.
CDC Pocket Guide: Tapering Opioids for Chronic Pain
Follow up regularly with patients to determine whether opioids are meeting treatment goals and whether opioids can be reduced to a lower dosage or discontinued.
The COVID-19 Pandemic: Practice and Policy Considerations For Patients with Opioid Use Disorder
This article details US policy updates that are loosening restrictions around MOUD prescribing in light of COVID-19.
The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder – 2020 Focused Update
The ASAM National Practice Guideline 2020 focused update is intended to inform and empower clinicians, health system administrators, criminal justice system administrators, and policymakers who are interested in implementing evidence-based practices to improve outcomes for individuals with OUD. This is especially critical in the context of the ongoing COVID-19 emergency, which threatens to curtail patient access to evidence-based treatment.
Minnesota Opioid Prescribing Guidelines, First Edition 2018
These prescribing guidelines address opioid use throughout the pain continuum with a particular focus on the critical treatment period during acute pain and recovery from surgeries and injuries.
Framing Opioid Prescribing Guidelines for Acute Pain: Developing the Evidence
This report recommends two frameworks—an analytic framework and an evidence evaluation framework—that medical professional societies, health care organizations, and state, national, and local agencies could use to develop CPGs for prescribing opioids to manage acute pain.
FDA issues warning for products marketed to treat opioid withdrawal
The FDA sent a warning letter to EPH Technologies, accusing it of marketing and selling unapproved drugs.
CDC Opioid Prescribing Guidelines
This guideline provides recommendations for primary care clinicians who are prescribing opioids for chronic pain outside of active cancer treatment, palliative care, and end-of-life care.